HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Ginkgo Bioworks (DNA) Investors with $150K+ Losses to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations SAN FRANCISCO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now. Visit:...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Ginkgo Bioworks (DNA) Investors to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations SAN FRANCISCO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now. Visit:...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Ginkgo Bioworks (DNA) Investors to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now. Visit:...

U.S. Defense Forensic Science Center to Use New Genetics Technology to Aid Investigations COLUMBUS, OH--(Marketwired - August 19, 2015) - Battelle's revolutionary new software, ExactID®, will be engaged by investigators at the U.S. Defense Forensic Science Center under a new agreement....